Kexing Biopharm Co Ltd banner

Kexing Biopharm Co Ltd
SSE:688136

Watchlist Manager
Kexing Biopharm Co Ltd Logo
Kexing Biopharm Co Ltd
SSE:688136
Watchlist
Price: 31.33 CNY 1.16% Market Closed
Market Cap: ¥6.3B

Kexing Biopharm Co Ltd
Investor Relations

Kexing Biopharm Co Ltd, formerly Shan Dong Kexing Bioproducts Co Ltd, is a China-based company principally involved in the research and development, manufacturing and sales of recombinant protein drugs and microecological preparations. Its products are the recombinant protein therapeutics 'Recombinant Human Erythropoietin', 'Recombinant Human Interferon α1b and Recombinant Human Granulocyte Colony-stimulating Factor, as well as the microbiota agents Combined Clostridium Butyricum and Bifidobacterium, etc. The Company's products are used for the therapeutic fields of antiviral, hematology, oncology and immunology, and degenerative diseases

Show more
Loading
688136
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
SHANDONG
Jinan
No.2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District
Contacts
+8675586967773
www.kexing.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett